Literature DB >> 17478956

Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population.

Roshandel Gholamreza1, Semnani Shahryar, Keshtkar Abbasali, Joshaghani Hamidreza, Moradi Abdolvahab, Kalavi Khodaberdi, Roshandel Danyal, Abdolahi Nafiseh.   

Abstract

CONTEXT: Hepatitis B virus (HBV) infection is one of the most prevalent public health problems worldwide (especially in developing countries). AIMS: This study was carried out to determine the seroprevalence of HBV and its co-infection with hepatitis D (HDV) and C (HCV) viruses in the northeastern part of Iran. SETTING AND
DESIGN: A population-based cross-sectional study in Iran.
MATERIALS AND METHODS: As many as 1,850 subjects were explored for HBsAg. Anti-HDV and anti-HCV antibodies were assessed in HBsAg-positive cases. STATISTICAL ANALYSIS USED: Proportions were compared by Chi-square and Fisher's exact tests.
RESULTS: The mean age of subjects was 43.86 +/- 11.2 years. The age- and sex-standardized prevalence for HBsAg positivity was 9.7%. It was higher in males than in females (OR: 1.28; 95% CI: 0.9-1.7). The risk of infection in singles was significantly higher than in married cases (OR: 2.13). Eight (5.8%) of HBsAg-positive cases were infected with HDV and 17 (12.3%) were positive for anti-HCV antibody.
CONCLUSION: This study demonstrates that the prevalence of HBsAg seropositivity in Golestan province of Iran is higher than the levels reported by WHO and previous studies from Iran. It is very important, especially for health providers and policy makers, to recognize the risk factors of HBV infection and its co-infection with HDV and HCV in this area and design effective preventive programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478956

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  21 in total

1.  Mutations in the S gene region of hepatitis B virus genotype D in Golestan Province-Iran.

Authors:  Abdolvahab Moradi; Sareh Zhand; Amir Ghaemi; Naeme Javid; Alijan Tabarraei
Journal:  Virus Genes       Date:  2012-01-25       Impact factor: 2.332

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran.

Authors:  Sareh Zhand; Alijan Tabarraei; Amineh Nazari; Abdolvahab Moradi
Journal:  Indian J Gastroenterol       Date:  2017-07-25

Review 4.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

5.  Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.

Authors:  Raika Jamali; Mahmoodreza Khonsari; Shahin Merat; Masoud Khoshnia; Elham Jafari; Alireza Bahram Kalhori; Hassan Abolghasemi; Sedighe Amini; Mahtab Maghsoudlu; Mohammad-Reza Deyhim; Houri Rezvan; Akram Pourshams
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iran.

Authors:  Mohammad-Reza Ghadir; Mojtaba Belbasi; Akram Heidari; Seyed Saeid Sarkeshikian; Alireza Kabiri; Amir Hossein Ghanooni; Abolfazl Iranikhah; Maryam Vaez-Javadi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

7.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

8.  Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?

Authors:  Elisabeth Smolle; Evelyn Zöhrer; Kira Bettermann; Johannes Haybaeck
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

9.  Prevalence of chronic hepatitis B infection in Iran: a review article.

Authors:  Jalal Poorolajal; Reza Majdzadeh
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

10.  Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Yaser Saiedi Hosseini; Seyed Hossein Aalaei Andabili
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.